|
|
|
Insider
Information: |
Matsui Connie |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
266,508 |
|
Indirect Shares
|
40,766 |
|
|
Direct
Value |
$11,998,699 |
|
|
Indirect Value
|
$8,516,017 |
|
|
Total
Shares |
307,274 |
|
|
Total
Value |
$20,514,717 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
Percentage
Gain/Loss : |
-16.5%
|
66.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
EVP, Corp. Strategy an... |
2007-02-12 |
22,837 |
2007-02-12 |
40,766 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
|
2023-05-05 |
187,004 |
|
0 |
Premium* |
|
Artelo Biosciences, Inc. |
ARTL |
|
2020-05-04 |
56,667 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
|
|
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,065 |
187,004 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
|
|
2022-11-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,250 |
178,939 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2021-11-05 |
4 |
S |
$40.13 |
$1,292,113 |
D/D |
(32,000) |
181,983 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,230 |
213,983 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2020-09-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,000 |
208,753 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2020-09-11 |
4 |
S |
$27.06 |
$865,792 |
D/D |
(32,000) |
216,753 |
0 |
% |
|
ARTL |
Artelo Biosciences, Inc. |
|
|
2020-05-04 |
4 |
B |
$1.20 |
$50,000 |
D/D |
41,667 |
56,667 |
0.01 |
% |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2020-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,829 |
248,753 |
0 |
- |
|
ARTL |
Artelo Biosciences, Inc. |
|
|
2019-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,000 |
|
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2019-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,173 |
239,924 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2018-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
227,751 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2018-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,363 |
242,751 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2017-09-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
232,388 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2017-05-08 |
4 |
OE |
$10.37 |
$103,700 |
D/D |
10,000 |
247,388 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,135 |
237,388 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2016-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
20,202 |
223,253 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2015-09-14 |
4 |
OE |
$2.33 |
$72,700 |
D/D |
20,000 |
203,051 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,175 |
183,051 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2014-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
24,876 |
169,876 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2013-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
145,000 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
125,000 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-05-05 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
105,000 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2010-05-06 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
85,000 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2009-05-07 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
65,000 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2008-05-08 |
4 |
A |
$4.94 |
$74,100 |
D/D |
15,000 |
45,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|